Editorial: Antidepressants in the treatment of stroke

Expert Review of Neurotherapeutics

Volumn 10, Issue 8, 2010, Pages 1237-1241

  Burns, Megan M ^a   Greenberg, David A ^a  

^a NONE

Author keywords

antidepressants; neurogenesis; neuroprotection; neurorepair; stroke

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; ESCITALOPRAM; FLUOXETINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; REBOXETINE; SERTRALINE; TRANYLCYPROMINE; NEUROPROTECTIVE AGENT;

BRAIN ISCHEMIA; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; EDITORIAL; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; SINGLE DRUG DOSE; STROKE; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; DEPRESSION; HUMANS; NEUROPROTECTIVE AGENTS; STROKE; TREATMENT OUTCOME;

EID: 77955077325     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.96     Document Type: Editorial

References (55)

1. Starkstein SE, Mizrahi R, Power BD. Antidepressant therapy in post-stroke depression. Expert Opin. Pharmacother. 9, 1291-1298 (2008).
2. Yulug B. Neuroprotective treatment strategies for poststroke mood disorders: a minireview on atypical neuroleptic drugs and selective serotonin re-uptake inhibitors. Brain Res. Bull. 80, 95-99 (2009).
3. Nakata N, Kato H, Kogure K. Protective effects of serotonin reuptake inhibitors, citalopram and clomipramine, against hippocampal CA1 neuronal damage following transient ischemia in the gerbil. Brain Res. 590, 48-52 (1992).
4. Kim DH, Li H, Yoo KY, Lee BH, Hwang IK, Won MH. Effects of fuoxetine on ischemic cells and expressions in BDNF and some antioxidants in the gerbil hippocampal CA1 region induced by transient ischemia. Exp. Neurol. 204, 748-758 (2007).
5. Zhang WH, Wang H, Wang X et al. Nortriptyline protects mitochondria and reduces cerebral ischemia/hypoxia injury. Stroke 39, 455-462 (2008).
6. Lim CM, Kim SW, Park JY, Kim C, Yoon SH, Lee JK. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-infammatory effect. J. Neurosci. Res. 87, 1037-1045 (2009).
7. Jin K, Minami M, Lan JQ et al. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc. Natl Acad. Sci. USA 98, 4710-4715 (2001).
8. Jin K, Wang X, Xie L et al. Evidence for stroke-induced neurogenesis in the human brain. Proc. Natl Acad. Sci. USA 103, 13198-13202 (2006).
9. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 8, 963-970 (2002).
10. Raber J, Fan Y, Matsumori Y et al. Irradiation attenuates neurogenesis and exacerbates ischemia-induced defcits. Ann. Neurol. 55, 381-389 (2004).
11. Jin K, Wang X, Xie L, Mao XO, Greenberg DA. Transgenic ablation of doublecortin-expressing cells suppresses adult neurogenesis and worsens stroke outcome in mice. Proc. Natl Acad. Sci. USA 107(17), 7993-7938 (2010).
12. Manev H, Uz T, Smalheiser NR, Manev R. Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur. J. Pharmacol. 411, 67-70 (2001).
13. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20, 9104-9110 (2000).
14. Keilhoff G, Becker A, Grecksch G, Bernstein HG, Wolf G. Cell proliferation is infuenced by bulbectomy and normalized by imipramine treatment in a region-specifc manner. Neuropsychopharmacology 31, 1165-1176 (2006).
15. Hitoshi S, Maruta N, Higashi M, Kumar A, Kato N, Ikenaka K. Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress. J. Neurosci. Res. 85, 3574-3585 (2007).
16. Lau WM, Qiu G, Helmeste DM, Lee TM, Tang SW, So KF. Corticosteroid decreases subventricular zone cell proliferation, which could be reversed by paroxetine. Restor. Neurol. Neurosci. 25, 17-23 (2007).
17. Arias-Carrion O, Verdugo-Diaz L, Feria-Velasco A et al. Neurogenesis in the subventricular zone following transcranial magnetic feld stimulation and nigrostriatal lesions. J. Neurosci. Res. 78, 16-28 (2004).
18. van Praag H, Christie BR, Sejnowski TJ, Gage FH. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc. Natl Acad. Sci. USA 96, 13427-13431 (1999).
19. David DJ, Samuels BA, Rainer Q et al. Neurogenesis-dependent and-independent effects of fuoxetine in an animal model of anxiety/depression. Neuron 62, 479-493 (2009).
20. Brezun JM, Daszuta A. Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience 89, 999-1002 (1999).
21. Jha S, Rajendran R, Davda J, Vaidya VA. Selective serotonin depletion does not regulate hippocampal neurogenesis in the adult rat brain: differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine. Brain Res. 1075, 48-59 (2006).
22. Van Kampen JM, Hagg T, Robertson HA. Induction of neurogenesis in the adult rat subventricular zone and neostriatum following dopamine D3 receptor stimulation. Eur. J. Neurosci. 19, 2377-2387 (2004).
23. Hoglinger GU, Rizk P, Muriel MP et al. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat. Neurosci. 7, 726-735 (2004).
24. Baker SA, Baker KA, Hagg T. Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone. Eur. J. Neurosci. 20, 575-579 (2004).
25. Kulkarni VA, Jha S, Vaidya VA. Depletion of norepinephrine decreases the proliferation, but does not infuence the survival and differentiation, of granule cell progenitors in the adult rat hippocampus. Eur. J. Neurosci. 16, 2008-2012 (2002).
26. Yanpallewar SU, Fernandes K, Marathe SV et al. a2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment. J. Neurosci. 30, 1096-1109 (2010).
27. Rizk P, Salazar J, Raisman-Vozari R et al. The a2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells. Neuropsychopharmacology 31, 1146-1157 (2006).
28. Jhaveri DJ, Mackay EW, Hamlin AS et al. Norepinephrine directly activates adult hippocampal precursors via b3-adrenergic receptors. J. Neurosci. 30, 2795-2806 (2010).
29. Hagg T. From neurotransmitters to neurotrophic factors to neurogenesis. Neuroscientist 15, 20-27 (2009).
30. Pencea V, Bingaman KD, Wiegand SJ, Luskin MB. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J. Neurosci. 21, 6706-6717 (2001).
31. Benraiss A, Chmielnicki E, Lerner K, Roh D, Goldman SA. Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J. Neurosci. 21, 6718-6731 (2001).
32. Wagner JP, Black IB, DiCicco-Bloom E. Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fbroblast growth factor. J. Neurosci. 19, 6006-6016 (1999).
33. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl Acad. Sci. USA 99, 11946-11950 (2002).
34. Greenberg DA, Jin K. Growth factors and stroke. NeuroRx 3, 458-465 (2006).
35. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15, 7539-7547 (1995).
36. Mallei A, Shi B, Mocchetti I. Antidepressant treatments induce the expression of basic fbroblast growth factor in cortical and hippocampal neurons. Mol. Pharmacol. 61, 1017-1024 (2002).
37. Warner-Schmidt JL, Duman RS. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc. Natl Acad. Sci. USA 104, 4647-4652 (2007).
38. Choi YS, Cho KO, Kim SY. Fluoxetine does not affect the ischemia-induced increase of neurogenesis in the adult rat dentate gyrus. Arch. Pharm. Res. 30, 641-645 (2007).
39. Li WL, Cai HH, Wang B et al. Chronic fuoxetine treatment improves ischemia-induced spatial cognitive defcits through increasing hippocampal neurogenesis after stroke. J. Neurosci. Res. 87, 112-122 (2009).
40. Schiavon AP, Milani H, Romanini CV et al. Imipramine enhances cell proliferation and decreases neurodegeneration in the hippocampus after transient global cerebral ischemia in rats. Neurosci. Lett. 470, 43-48 (2010).
41. Goldstein LB. Effects of amphetamines and small related molecules on recovery after stroke in animals and man. Neuropharmacology 39, 852-859 (2000).
42. Boyeson MG, Harmon RL. Effects of trazodone and desipramine on motor recovery in brain-injured rats. Am. J. Phys. Med. Rehabil. 72, 286-293 (1993).
43. Boyeson MG, Harmon RL, Jones JL. Comparative effects of fuoxetine, amitriptyline and serotonin on functional motor recovery after sensorimotor cortex injury. Am. J. Phys. Med. Rehabil. 73, 76-83 (1994).
44. Chang YC, Tzeng SF, Yu L et al. Early-life fuoxetine exposure reduced functional defcits after hypoxic-ischemia brain injury in rat pups. Neurobiol. Dis. 24, 101-113 (2006).
45. Maya Vetencourt JF, Sale A, Viegi A et al. The antidepressant fuoxetine restores plasticity in the adult visual cortex. Science 320, 385-388 (2008).
46. Ramasubbu R, Robinson RG, Flint AJ, Kosier T, Price TR. Functional impairment associated with acute poststroke depression: the Stroke Data Bank Study. J. Neuropsychiatry Clin. Neurosci. 10, 26-33 (1998).
47. Dam M, Tonin P, De Boni A et al. Effects of fuoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 27, 1211-1214 (1996). (Pubitemid 26226957)
48. Miyai I, Reding MJ. Effects of antidepressants on functional recovery following stroke: a double-blind study. J. Neurol. Rehabil. 12, 5-13 (1998).
49. Narushima K, Paradiso S, Moser DJ, Jorge R, Robinson RG. Effect of antidepressant therapy on executive function after stroke. Br. J. Psychiatry 190, 260-265 (2007).
50. Jorge RE, Robinson RG, Arndt S, Starkstein S. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am. J. Psychiatry 160, 1823-1829 (2003).
51. Zittel S, Weiller C, Liepert J. Citalopram improves dexterity in chronic stroke patients. Neurorehabil. Neural Repair 22, 311-314 (2008).
52. Acler M, Robol E, Fiaschi A, Manganotti P. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J. Neurol. 256, 1152-1158 (2009).
53. Jorge RE, Acion L, Moser D, Adams HP Jr, Robinson RG. Escitalopram and enhancement of cognitive recovery following stroke. Arch. Gen. Psychiatry 67, 187-196 (2010).
54. Laska AC, von Arbin M, Kahan T, Hellblom A, Murray V. Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study. Cerebrovasc. Dis. 19, 125-132 (2005).
55. Murase N, Duque J, Mazzocchio R, Cohen LG. Infuence of interhemispheric interactions on motor function in chronic stroke. Ann. Neurol. 55, 400-409 (2004).